0001429386-16-000002.txt : 20160609 0001429386-16-000002.hdr.sgml : 20160609 20160609122958 ACCESSION NUMBER: 0001429386-16-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160609 DATE AS OF CHANGE: 20160609 EFFECTIVENESS DATE: 20160609 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PHASERX, INC. CENTRAL INDEX KEY: 0001429386 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 204690620 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-264676 FILM NUMBER: 161705335 BUSINESS ADDRESS: STREET 1: 410 WEST HARRISON STREET STREET 2: SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98119 BUSINESS PHONE: 206-805-6300 MAIL ADDRESS: STREET 1: 410 WEST HARRISON STREET STREET 2: SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98119 FORMER COMPANY: FORMER CONFORMED NAME: PHASERX INC DATE OF NAME CHANGE: 20080311 D 1 primary_doc.xml X0707 D LIVE 0001429386 PHASERX, INC. 410 WEST HARRISON STREET SUITE 300 SEATTLE WA WASHINGTON 98119 206-805-6300 DELAWARE PHASERX INC Corporation true ROBERT W. OVERELL 410 WEST HARRISON STREET SUITE 300 SEATTLE WA WASHINGTON 98119 Executive Officer Director Promoter Michael Houston 410 WEST HARRISON STREET SUITE 300 SEATTLE WA WASHINGTON 98119 Executive Officer BRIAN ATWOOD 3000 SAND HILL ROAD BUILDING 4, SUITE 210 MENLO PARK CA CALIFORNIA 94025 Director Richard Ulevitch 1001 GENTER ST APT 7F LA JOLLA CA CALIFORNIA 92037 Director STEVEN GILLIS 8725 WEST HIGGINS ROAD SUITE 290 CHICAGO IL ILLINOIS 60631 Director PAUL JOHNSON 410 WEST HARRISON STREET SUITE 300 SEATTLE WA WASHINGTON 98119 Executive Officer Director JOHN SCHMIDT 410 WEST HARRISON STREET SUITE 300 SEATTLE WA WASHINGTON 98119 Director Michelle Griffin 410 WEST HARRISON STREET SUITE 300 SEATTLE WA WASHINGTON 98119 Director Shing-Yin (Helen) Tsui 410 WEST HARRISON STREET SUITE 300 SEATTLE WA WASHINGTON 98119 Executive Officer Biotechnology Decline to Disclose 06b false 2016-06-07 false true true true Warrants to purchase Common Stock. false 0 420000 0 420000 Total Offering Amount is the amount Issuer may receive upon exercise of warrants. Warrants may be exercised for shares of Common Stock for an aggregate exercise price of (a) an initial $315,000 and, (b) if certain conditions occur, an additional $105,000. false 1 0 0 0 false PHASERX, INC. /s/ Robert W. Overell ROBERT W. OVERELL PRESIDENT AND CHIEF EXECUTIVE OFFICER 2016-06-09